{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:40:29Z","timestamp":1788784829487,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Government of India Department of Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115753","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:53:01Z","timestamp":1761871981000},"page":"115753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting the epigenetic regulator bromodomain-containing protein 4 by BRD4 siRNA lipoplexes and PFI-1 in psoriasis"],"prefix":"10.1016","volume":"167","author":[{"given":"Sowjanya","family":"Thatikonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Pooladanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Devabattula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115753_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0010","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/0019-5154.113948","article-title":"A study of various histopathological features and their relevance in pathogenesis of psoriasis","volume":"58","author":"Moorchung","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115753_bb0020","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1038\/s41598-019-43899-9","article-title":"Th1, Th17, and Treg responses are differently modulated by TNF-\u03b1 inhibitors and methotrexate in psoriasis patients","volume":"9","author":"Furiati","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.115753_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2405291","article-title":"Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis","author":"Tan","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"35","key":"10.1016\/j.intimp.2025.115753_bb0030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1358\/dot.1999.35.12.564038","article-title":"The pathophysiological role of cytokines in psoriasis","volume":"1998","author":"Asadullah","year":"1999","journal-title":"Drugs Today Barc. Spain"},{"key":"10.1016\/j.intimp.2025.115753_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/1744666X.2017.1292137","article-title":"The role of IL 23 in the treatment of psoriasis","volume":"13","author":"Puig","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2025.115753_bb0040","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115753_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2009.252","article-title":"A role for TGF\u03b2 signaling in the pathogenesis of psoriasis","volume":"130","author":"Han","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","article-title":"The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin","volume":"152","author":"Johansen","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0923-1811(02)00064-6","article-title":"Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis","volume":"30","author":"Takahashi","year":"2002","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0060","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/ijd.12050","article-title":"Role of NF-\u03baB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens","volume":"53","author":"Moorchung","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-\u03baB: an essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/genes6030607","article-title":"Nucleosome dancing at the tempo of histone tail acetylation","volume":"6","author":"Galvani","year":"2015","journal-title":"Genes"},{"key":"10.1016\/j.intimp.2025.115753_bb0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbagrm.2014.03.011","article-title":"The bromodomain: from epigenome reader to druggable target","volume":"1839","author":"Sanchez","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2025.115753_bb0090","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1074\/jbc.R700001200","article-title":"The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation","volume":"282","author":"Wu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.115753_bb0095","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2025.115753_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","article-title":"Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4","volume":"19","author":"Yang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2025.115753_bb0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115753_bb0110","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.1093\/nar\/gkx802","article-title":"RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN","volume":"45","author":"Sancisi","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.115753_bb0115","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115753_bb0120","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1158\/1535-7163.MCT-15-0037","article-title":"Sensitivity of small cell lung cancer to BET inhibition is mediated by regulation of ASCL1 gene expression","volume":"14","author":"Lenhart","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2025.115753_bb0125","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/ijms16011928","article-title":"BRD4 inhibitor inhibits colorectal cancer growth and metastasis","volume":"16","author":"Hu","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0130","doi-asserted-by":"crossref","first-page":"L621","DOI":"10.1152\/ajplung.00436.2018","article-title":"Decreased miR-29b expression is associated with airway inflammation in chronic obstructive pulmonary disease","volume":"316","author":"Tang","year":"2019","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2025.115753_bb0135","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1111\/jcmm.14196","article-title":"BRD4 inhibition attenuates inflammatory response in microglia and facilitates recovery after spinal cord injury in rats","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115753_bb0140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/v12040472","article-title":"RSV reprograms the CDK9\u2022BRD4 chromatin remodeling complex to couple innate inflammation to airway remodeling","volume":"12","author":"Brasier","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2025.115753_bb0145","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.bbadis.2017.08.009","article-title":"BRD4 has dual effects on the HMGB1 and NF-\u03baB signalling pathways and is a potential therapeutic target for osteoarthritis","volume":"1863","author":"Jiang","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.intimp.2025.115753_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109368","article-title":"BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation","volume":"121","author":"Zhu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115753_bb0155","doi-asserted-by":"crossref","first-page":"E3993","DOI":"10.1073\/pnas.1700109114","article-title":"Brd4 modulates the innate immune response through Mnk2\u2013eIF4E pathway-dependent translational control of I\u03baB\u03b1","volume":"114","author":"Bao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115753_bb0160","first-page":"5227","article-title":"miR-125b-mediated regulation of cell proliferation through the Jagged-1\/notch signaling pathway by inhibiting BRD4 expression in psoriasis","volume":"19","author":"Pan","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2025.115753_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14712\/fb2024070010053","article-title":"Gallic acid alleviates psoriasis keratinization and inflammation by regulating BRD4 expression","volume":"70","author":"Zhang","year":"2024","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.intimp.2025.115753_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-biophys-083012-130404","article-title":"Molecular mechanisms of RNA interference","volume":"42","author":"Wilson","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.intimp.2025.115753_bb0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52012","article-title":"A molecular view on the escape of lipoplexed DNA from the endosome","volume":"9","author":"Bruininks","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.intimp.2025.115753_bb0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature16508","article-title":"Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer","volume":"529","author":"Shu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115753_bb0185","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/JVI.80.9.4276-4285.2006","article-title":"Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function","volume":"80","author":"Schweiger","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2025.115753_bb0190","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.gt.3302231","article-title":"Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo","volume":"11","author":"Chen","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.intimp.2025.115753_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2016.00940","article-title":"Using HEK293T expression system to study photoactive plant Cryptochromes","volume":"7","author":"Yang","year":"2016","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0200","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.2147\/IJN.S136426","article-title":"Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation","author":"Kubota","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2025.115753_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2018.08.024","article-title":"Dendrimer as a new potential carrier for topical delivery of siRNA: a comparative study of dendriplex vs. lipoplex for delivery of TNF-\u03b1 siRNA","volume":"550","author":"Pandi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2025.115753_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115753_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120536","article-title":"BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome","volume":"601","author":"Pooladanda","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2025.115753_bb0220","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/jcp.29413","article-title":"Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation","volume":"235","author":"Thatikonda","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2025.115753_bb0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.intimp.2019.03.035","article-title":"Protective effects of ambroxol in psoriasis like skin inflammation: exploration of possible mechanisms","volume":"71","author":"Sunkari","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115753_bb0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12951-021-00842-3","article-title":"Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation","volume":"19","author":"Gangadevi","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2025.115753_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102351","article-title":"iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome","volume":"33","author":"Pooladanda","year":"2021","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.intimp.2025.115753_bb0240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-018-1247-9","article-title":"Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-\u03b1 mediated NF-\u03baB and HDAC-3 nuclear translocation","volume":"10","author":"Pooladanda","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115753_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018218","article-title":"Improved elution conditions for native co-immunoprecipitation","volume":"6","author":"Antrobus","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115753_bb0250","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1158\/1078-0432.CCR-16-0453","article-title":"The MAPK pathway regulates intrinsic resistance to BET inhibitors in colorectal cancer","volume":"23","author":"Ma","year":"2017","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115753_bb0255","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x202010109","article-title":"4\u2019-O-\u03b2-D-glucosyl-5-O-methylvisamminol ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production by suppressing the NF-\u03baB and MAPK signaling pathways","volume":"53","author":"Fu","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.intimp.2025.115753_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1510-8","article-title":"Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115753_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/986265","article-title":"Formulation strategies, characterization, and in vitro evaluation of lecithin-based nanoparticles for siRNA delivery","volume":"2012","author":"P\u00e9rez","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.intimp.2025.115753_bb0270","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.5958\/0974-360X.2020.00621.6","article-title":"Imiquimod-induced psoriasis mice model: a promising tool for psoriasis research?","volume":"13","author":"Badanthadka","year":"2020","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.intimp.2025.115753_bb0275","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2025.115753_bb0280","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/569751","article-title":"The role of p38 MAPK in the Aetiopathogenesis of psoriasis and psoriatic arthritis","volume":"2013","author":"Mavropoulos","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2025.115753_bb0285","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/jid.2013.182","article-title":"NF-\u03baB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH","volume":"133","author":"Andr\u00e9s","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bip.21546","article-title":"Protein-protein interactions in transcription: a fertile ground for Helix mimetics","volume":"95","author":"Guarracino","year":"2011","journal-title":"Biopolymers"},{"key":"10.1016\/j.intimp.2025.115753_bb0295","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 family of cytokines in psoriasis: IL-17A and beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115753_bb0300","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 Axis in the Immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0305","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1073\/pnas.1433065100","article-title":"The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis","volume":"100","author":"Dey","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0310","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The Bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2025.115753_bb0315","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000744","article-title":"Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases","volume":"4","author":"Klein","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.intimp.2025.115753_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095051","article-title":"Brd4 is essential for IL-1\u03b2-induced inflammation in human airway epithelial cells","volume":"9","author":"Khan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115753_bb0325","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellimm.2019.02.001","article-title":"Emerging roles of and therapeutic strategies targeting BRD4 in cancer","volume":"337","author":"White","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2025.115753_bb0330","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"issue":"190","key":"10.1016\/j.intimp.2025.115753_bb0335","first-page":"3670","article-title":"BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses","volume":"1950","author":"Belkina","year":"2013","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2025.115753_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115753_bb0345","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2012.318","article-title":"An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor A signaling","volume":"133","author":"El Malki","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0350","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1189\/jlb.1112562","article-title":"Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation","volume":"94","author":"Yanaba","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2025.115753_bb0355","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12906-016-1325-4","article-title":"Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2025.115753_bb0360","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2230.2009.03774.x","article-title":"Expression of cyclin D1 and p16 in psoriasis before and after phototherapy","volume":"35","author":"Abou EL-Ela","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.intimp.2025.115753_bb0365","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.7150\/ijms.20809","article-title":"IL-36\u03b3 inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis","volume":"14","author":"Wang","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.intimp.2025.115753_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105158","article-title":"An optimized BRD4 inhibitor effectively eliminates NF-\u03baB-driven triple-negative breast cancer cells","volume":"114","author":"Yang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.intimp.2025.115753_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2016.12.022","article-title":"Distinct roles of Brd2 and Brd4 in potentiating the transcriptional program for Th17 cell differentiation","volume":"65","author":"Cheung","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2025.115753_bb0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12938-021-00943-y","article-title":"Inhibition of BRD4 inhibits proliferation and promotes apoptosis of psoriatic keratinocytes","volume":"20","author":"Sun","year":"2021","journal-title":"Biomed. Eng. Online"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2025.115978","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:57:04Z","timestamp":1771520224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925017412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":76,"alternative-id":["S1567576925017412"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115753","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the epigenetic regulator bromodomain-containing protein 4 by BRD4 siRNA lipoplexes and PFI-1 in psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115753"}}